BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6141554)

  • 1. Effects of 6-hydroxydopamine-induced lesions of A10 dopaminergic neurons and neuroleptic or bromocriptine treatment on ethanol withdrawal syndrome in rats.
    Trzaskowska E; Puciłowski O; Kostowski W; Bidziński A
    Pol J Pharmacol Pharm; 1983; 35(5):339-49. PubMed ID: 6141554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of agonists and antagonists of dopaminergic system on the formation of audiogenic seizures in rats during the ethanol abstinence period.
    Kaliszuk S; Borzecki Z; Swies Z
    Ann Univ Mariae Curie Sklodowska Med; 1990; 45():163-7. PubMed ID: 1688311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the relative importance of D-1 vs. D-2 dopaminergic receptors in the control of audiogenic seizures in ethanol withdrawn rats.
    Trzaskowska E; Krzaścik P; Staniszewska A; Puciłowski O; Kostowski W
    Drug Alcohol Depend; 1989 Dec; 24(3):265-7. PubMed ID: 2691221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on the role of noradrenergic mechanisms in ethanol withdrawal syndrome in rats.
    Trzaskowska E; Kostowski W
    Pol J Pharmacol Pharm; 1983; 35(5):351-8. PubMed ID: 6686675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of escitalopram on ethanol withdrawal syndrome in rats.
    Sağlam E; Kayir H; Celik T; Uzbay T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1027-32. PubMed ID: 16650516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats.
    Uzbay IT; Akarsu ES; Kayaalp SO
    Pharmacol Biochem Behav; 1994 Dec; 49(4):969-74. PubMed ID: 7886115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric cytoprotection induced by prostaglandin-dopaminergic mechanism.
    Laudanno OM; Bedini OA; San Miguel P; Cesolari JA
    Acta Gastroenterol Latinoam; 1987; 17(4):299-303. PubMed ID: 2905107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and serotonin release-regulating autoreceptor sensitivity in A9/A10 cell body and terminal areas after withdrawal of rats from continuous infusion of cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1445-53. PubMed ID: 8263807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
    Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
    Sprah L; Zivin M; Sket D
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor.
    Michael-Titus A; Preterre P; Giros B; Costentin J
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1062-6. PubMed ID: 3121843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of dopamine neurotransmission on the development of ethanol dependence and course of abstinence syndrome].
    Samochowiec J
    Ann Acad Med Stetin; 1994; 40():195-217. PubMed ID: 7503446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic tianeptine treatments attenuate ethanol withdrawal syndrome in rats.
    Uzbay T; Kayir H; Celik T; Yüksel N
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):478-85. PubMed ID: 16412550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The action of low doses of bromocryptin in experimental morphine abstinence in rats].
    Stanishevskaia AV; Khristoliubova NA; Vekshina NL; Varfolomeev SO; Anokhina IP
    Farmakol Toksikol; 1991; 54(3):15-7. PubMed ID: 1655521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The brain dopamine receptors in chronically alcoholized animals with different relationships to alcohol].
    Bondarenko TT; Vekshina NL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(1):168-71. PubMed ID: 1316008
    [No Abstract]   [Full Text] [Related]  

  • 18. Withdrawal from intermittent ethanol exposure increases probability of burst firing in VTA neurons in vitro.
    Hopf FW; Martin M; Chen BT; Bowers MS; Mohamedi MM; Bonci A
    J Neurophysiol; 2007 Oct; 98(4):2297-310. PubMed ID: 17699688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 6-hydroxydopamine-induced lesions of A10 dopaminergic neurons on aggressive behavior in rats.
    Puciłowski O; Kostowski W; Bidziński A; Hauptmann M
    Pharmacol Biochem Behav; 1982 Apr; 16(4):547-51. PubMed ID: 6803251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clozapine on ethanol withdrawal syndrome in rats.
    Kayir H; Uzbay T
    Alcohol Alcohol; 2008; 43(6):619-25. PubMed ID: 18579515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.